{
    "title": "Priced like an automaker, sputtering Gilead shares lure value bets",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4196948/Priced-like-automaker-sputtering-Gilead-shares-lure-value-bets.html",
    "date": "2017-02-06",
    "keywords": [
        "value",
        "percent",
        "growth",
        "gilead",
        "hepatitis",
        "c",
        "rate",
        "gmt",
        "biotechnology",
        "profit",
        "company",
        "decline",
        "stock",
        "research",
        "year",
        "automaker",
        "email",
        "krauskopfnew",
        "york",
        "feb",
        "inc",
        "outlook",
        "opportunity",
        "levelsat",
        "oncehighflying",
        "alltime",
        "mid",
        "basis",
        "valuation",
        "ford",
        "biotech",
        "morningstar",
        "rockbottom",
        "pe",
        "ratioone",
        "investor",
        "asset",
        "position",
        "investment",
        "officer",
        "base",
        "possibility",
        "easy",
        "youre",
        "report",
        "tuesday",
        "chance",
        "medicine",
        "wave",
        "competition",
        "sovaldi",
        "treatment",
        "liver",
        "disease",
        "process",
        "end",
        "uncertainty",
        "market",
        "pipeline",
        "thomson",
        "biotechs",
        "index",
        "sector",
        "president",
        "criticism",
        "drug",
        "multiple",
        "jason",
        "head",
        "maxim",
        "group",
        "acquisition",
        "growthgilead",
        "dividend",
        "merck",
        "zieminski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}